Centenial Surgical Suture Ltd operates in Medical Equipment & Supplies within the Healthcare sector.
1,583 historical price candles were omitted because the exchange source has not been verified.
No positive flags triggered.
Structured signal from quality, growth, valuation and momentum.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Standalone figures
| Ratio | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin % | — | — | 71.9% | 55.8% | 61.9% | 66.7% | 67.8% | 65.2% |
| EBITDA margin % | 9.4% | 10.4% | 13.5% | 10% | 8.2% | 9.8% | 11.7% | 9.5% |
| EBIT margin % | 8.1% | 7.6% | 9.3% | 6.6% | 5.7% | 7.1% | 3.8% | 2% |
| PAT margin % | 3.6% | 2.6% | 2.6% | 1.4% | 1.7% | 2.2% | -2.7% | -4.1% |
| Working capital | ||||||||
| Receivable days | 135 | 153 | 221 | 160 | 143 | 134 | 125 | 124 |
| Inventory days | 214 | 236 | 1,276 | 599 | 677 | 910 | 922 | 791 |
| Payable days | 59 | 92 | 373 | 159 | 222 | 208 | 152 | 146 |
| NWC days | 290 | 298 | 1,125 | 601 | 598 | 836 | 895 | 770 |
| Leverage | ||||||||
| Current ratio | 2 | 1.87 | 1.92 | 2.2 | 2.04 | 1.99 | 1.98 | 1.9 |
| Debt to EBITDA | — | — | 0 | 0 | 0 | 0 | 0 | 2.1 |
| Debt to equity | — | — | 0 | 0 | 0 | 0 | 0 | 0.38 |
| Interest coverage | 2.6 | 2 | 1.8 | 1.6 | 1.9 | 1.5 | 0.6 | 0.4 |
| Asset turnover | 0.99 | 0.8 | 0.53 | 0.72 | 0.79 | 0.65 | 0.63 | 0.67 |
| Return ratios | ||||||||
| Return on assets % | 3.6% | 2.1% | 1.4% | 1% | 1.3% | 1.4% | -1.7% | -2.8% |
| Return on capital employed % | 15.3% | 12.6% | 9.2% | 7.8% | 8.4% | 9% | 4.3% | 2.5% |
| Return on equity % | 7.2% | 5% | 3.2% | 2.1% | 2.9% | 3.5% | -4.7% | -7.7% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
| Holder (%) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 46.89% | 46.89% | 46.89% | 46.89% | 46.89% | 46.89% | 46.89% | 46.89% | 46.89% | 46.89% | 46.89% | 46.89% | |
| FII | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DII | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 53.11% | 53.11% | 53.11% | 53.11% | 53.11% | 53.11% | 53.11% | 53.11% | 53.11% | 53.11% | 53.11% | 53.11% | |
| No. of shareholders | — | — | — | — | — | — | — | — | 1,193 | 1,200 | 1,182 | 1,165 |
Promoter holding up 0 percentage points since Sep 2023.
| Date | Client | Type | Venue | Side | Quantity | Price | Value |
|---|---|---|---|---|---|---|---|
| 27 Jun 2023 | VIJAY KALIDAS MAJREKAR | Bulk | BSE | Buy | 51,326 | ₹64.15 | ₹0.33 Cr |
| 27 Jun 2023 | VIPUL NAVINCHANDRA SHAH | Bulk | BSE | Sell | 28,849 | ₹64.15 | ₹0.19 Cr |
| 24 May 2023 | VIPUL NAVINCHANDRA SHAH | Bulk | BSE | Buy | 28,849 | ₹64.75 | ₹0.19 Cr |
| 24 May 2023 | SHREE BHUVANAKARAM TRADINVEST PVT LTD | Bulk | BSE | Sell | 28,849 | ₹64.75 | ₹0.19 Cr |
Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.
Current officeholders as filed with BSE. A person holding two offices is listed once per office.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
No scheme among the 32 fund houses on record reported a position in Centenial Surgical Suture Ltd. Portfolios are published monthly by each AMC; coverage is still partial.
Documents link to external sources (exchange filings, company investor pages).
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| Molbio Diagnostics LimitedMOLBIOMOLBIO | ₹17,431 Cr | ₹17,844 Cr | ₹1,020 Cr | ₹262 Cr | 25.7% | ₹145 Cr | 13.6% | 23.7% | 16.2% | — |
| Poly Medicure LimitedPOLYMEDPOLYMED | ₹16,610 Cr | ₹16,952 Cr | ₹1,997 Cr | ₹461 Cr | 23.6% | ₹315 Cr | 17.1% | 14.5% | 11% | 294 |
| Fischer Medical Ventures LimitedFISCHERFISCHER | ₹2,190 Cr | ₹2,262 Cr | ₹367 Cr | ₹50 Cr | 14% | ₹30 Cr | 10.1% | 13.6% | 8.6% | 111 |
| Tarsons Products LimitedTARSONSTARSONS | ₹1,752 Cr | ₹2,135 Cr | ₹441 Cr | ₹119 Cr | 27.9% | ₹11 Cr | 3.4% | 5% | 2.3% | 361 |
| Laxmi Dental LimitedLAXMIDENTLLAXMIDENTL | ₹1,066 Cr | ₹1,066 Cr | ₹287 Cr | ₹46 Cr | 15.6% | ₹31 Cr | 10.4% | 14.7% | 12.8% | 109 |
| Hemant Surgical Industries LtdHSILHSIL | ₹885 Cr | — | ₹232 Cr | ₹23 Cr | 10% | ₹18 Cr | 7.9% | — | — | — |
| Fabtech Technologies LimitedFABTECHFABTECH | ₹632 Cr | ₹675 Cr | ₹418 Cr | ₹45 Cr | 8.5% | ₹49 Cr | 9.3% | 15.5% | 12.9% | 55 |
| Prevest Denpro LtdPREVESTPREVEST | ₹452 Cr | — | ₹72 Cr | ₹25 Cr | 34.4% | ₹20 Cr | 28.5% | — | — | — |
| Nureca LimitedNURECANURECA | ₹332 Cr | ₹333 Cr | ₹153 Cr | ₹4 Cr | 0.1% | ₹4 Cr | 1.4% | 3.3% | 1.1% | 186 |
| Earkart LtdEARKARTEARKART | ₹179 Cr | ₹179 Cr | ₹54 Cr | ₹8 Cr | 15.5% | ₹5 Cr | 9.1% | 12.1% | 7.7% | 243 |
| Choksi Asia LtdCHOKSICHOKSI | ₹117 Cr | ₹119 Cr | ₹11 Cr | ₹-2 Cr | 13.8% | ₹2 Cr | 10.8% | 18.9% | 13.5% | 142 |
| Shree Pacetronix LtdSHREEPACSHREEPAC | ₹68 Cr | ₹71 Cr | ₹8 Cr | ₹1 Cr | 23.5% | ₹0 Cr | 14% | 27.4% | 18.9% | 385 |
Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday, August 14, 2026 Pursuant To Regulation 30 Read With Schedule III(A)(IV) Of The SEBI (Listing Obligations And Disclosure Requirements [LODR]) Regulations, 2015.
Board Meeting Intimation for Approval Of Standalone Un-Audited Financial Results For The Quarter Ended June 30, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Announcement under Regulation 30 (LODR)-Change in Management
Closure of Trading Window
Announcement under Regulation 30 (LODR)-Newspaper Publication
Approval Of Standalone Audited Financial Results For The Quarter And Year Ended March 31, 2026 Along With Declaration And Auditor'S Report
Board Meeting Outcome for Outcome Of The Board Meeting Held On May 30 2026, Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements [LODR]) Regulations, 2015
| Date | Category | Subject | Filing |
|---|---|---|---|
| 14 Aug 2026, 6:20 pm | Board Meeting Outcome of Board Meeting | Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday, August 14, 2026 Pursuant To Regulation 30 Read With Schedule III(A)(IV) Of The SEBI (Listing Obligations And Disclosure Requirements [LODR]) Regulations, 2015. | |
| 3 Aug 2026, 9:23 pm | Board Meeting | Board Meeting Intimation for Approval Of Standalone Un-Audited Financial Results For The Quarter Ended June 30, 2026 |
| 8 Jul 2026, 10:16 pm | Company Update Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| 24 Jun 2026, 5:01 pm | Company Update Change in Management | Announcement under Regulation 30 (LODR)-Change in Management |
| 23 Jun 2026, 6:12 pm | Insider Trading / SAST Closure of Trading Window | Closure of Trading Window |
| 3 Jun 2026, 7:35 am | Company Update Newspaper Publication | Announcement under Regulation 30 (LODR)-Newspaper Publication |
| 30 May 2026, 6:58 pm | Result Financial Results | Approval Of Standalone Audited Financial Results For The Quarter And Year Ended March 31, 2026 Along With Declaration And Auditor'S Report |
| 30 May 2026, 6:52 pm | Board Meeting Outcome of Board Meeting | Board Meeting Outcome for Outcome Of The Board Meeting Held On May 30 2026, Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements [LODR]) Regulations, 2015 |
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | 53 | 53 | 56 | 56 | 37 | 44 | 53 | 51 | 54 | 54 | |
| COGS | -9 | -26 | -24 | -25 | -24 | 10 | 20 | 20 | 17 | 17 | 19 |
| Gross profit | — | — | — | — | — | 27 | 25 | 33 | 34 | 36 | 35 |
| 56 | 74 | 72 | 76 | 74 | 22 | 20 | 28 | 29 | 30 | 30 | |
| 4 | 5 | 4 | 5 | 6 | 5 | 4 | 4 | 5 | 6 | 5 | |
| OPM % | 8% | 9% | 8.3% | 9.4% | 10.4% | 13.5% | 10% | 8.2% | 9.8% | 11.7% | 9.5% |
| Depreciation | — | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 4 | 4 |
| Interest | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 3 |
| — | 0 | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit before tax | 2 | 3 | 2 | 3 | 2 | 2 | 1 | 1 | 1 | -2 | -2 |
| Tax | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | -0 | 0 |
| Tax % | 34% | 32.6% | 36.1% | 29.2% | 33.3% | 37.3% | 42.1% | 39.7% | 11% | -9.3% | 5.8% |
| 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | -1 | -2 | |
| PAT margin % | 3% | 3.3% | 2.9% | 3.6% | 2.6% | 2.6% | 1.4% | 1.7% | 2.2% | -2.7% | -4.1% |
| EPS (₹) | 4.2 | 4.7 | 4.2 | 4.4 | 4 | 2.6 | — | 2.4 | 3.1 | — | -6 |
| EPS adjusted (₹) | 2.9 | 3.2 | 2.8 | 3.7 | 2.7 | 1.8 | 1.2 | 1.6 | 2.1 | -2.7 | -4.1 |
| Annual report | Annual report for Mar 2016 | Annual report for Mar 2017 | Annual report for Mar 2018 | Annual report for Mar 2019 | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | — |
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 17 | 17 | 21 | 23 | 23 | 24 | 25 | 26 | 27 | 25 | 23 |
| Minority interest | — | 0 | — | 0 | 0 | — | 0 | — | 0 | — | — |
| 13 | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 11 | |
| 17 | 30 | 29 | 29 | 41 | 40 | 31 | 35 | 47 | 54 | 41 | |
| Total equity & liabilities | 53 | 53 | 55 | 57 | 69 | 70 | 61 | 66 | 79 | 85 | 80 |
| 4 | 4 | 4 | 4 | 10 | 9 | 8 | 6 | 13 | 20 | 18 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | — | 0 | — | — | — | 0 |
| Investments | 0 | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 |
| 49 | 49 | 51 | 52 | 59 | 61 | 54 | 60 | 66 | 65 | 62 | |
| Total assets | 53 | 53 | 55 | 57 | 69 | 70 | 61 | 66 | 79 | 85 | 80 |
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -2 | 0 | 2 | 2 | 2 | -0 | 3 | -0 | 4 | 13 | 4 | |
| -0 | -2 | -1 | -1 | -1 | -1 | -0 | -0 | -8 | -12 | -2 | |
| 1 | 2 | -1 | -1 | -0 | 1 | -3 | 1 | 5 | -2 | -2 | |
| Net cash flow | -1 | -0 | 0 | -1 | 0 | -0 | -0 | 0 | 0 | -0 | -0 |
| Free cash flow | -2 | -1 | 1 | 1 | 1 | -1 | 3 | -1 | -4 | 2 | 2 |
| CFO / Operating profit % | -36.9% | 0% | 40% | 29.5% | 35.9% | -1% | 64.3% | -8.6% | 74.9% | 212.6% | 78.4% |